Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790673 | SCV000230820 | pathogenic | not provided | 2014-04-14 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000178693 | SCV000485413 | likely pathogenic | Cohen syndrome | 2015-12-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000178693 | SCV002213583 | pathogenic | Cohen syndrome | 2021-03-08 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with VPS13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 167832). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu2982*) in the VPS13B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13B are known to be pathogenic (PMID: 15141358, 16648375, 20461111). |